Prelude Capital Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-147
Closed -$1K 1729
2019
Q4
$1K Sell
147
-15
-9% -$102 ﹤0.01% 1364
2019
Q3
$1K Buy
+162
New +$1K ﹤0.01% 1136
2017
Q4
Sell
-15,900
Closed -$63K 1676
2017
Q3
$63K Buy
15,900
+7,900
+99% +$31.3K 0.01% 937
2017
Q2
$41K Sell
8,000
-26,900
-77% -$138K ﹤0.01% 961
2017
Q1
$241K Buy
34,900
+23,500
+206% +$162K 0.02% 465
2016
Q4
$107K Buy
11,400
+5,600
+97% +$52.6K 0.01% 767
2016
Q3
$57K Buy
5,800
+800
+16% +$7.86K 0.01% 942
2016
Q2
$71K Sell
5,000
-2,047
-29% -$29.1K 0.01% 834
2016
Q1
$99K Buy
7,047
+3,151
+81% +$44.3K 0.01% 699
2015
Q4
$79K Buy
+3,896
New +$79K 0.01% 844
2015
Q3
Sell
-215
Closed -$3K 1796
2015
Q2
$3K Buy
+215
New +$3K ﹤0.01% 1534